Float is too low to discount a pullback. All it takes is 30-50k shares to the downside to break the triangle currently forming. Having said that, yes the bid is showing impressive strength which could portend another move up if it gets above $9.30-9.40. Place your bets accordingly.
Please for God's sake look at a chart.
7.50 would be the first pullback,.... then if there was a selloff,... to 6.50,.... then 6 and back to $5.50.
That's only 3 months ago..... now I'm not saying its gonna go there (but if the market went south, this definetly would, cause they have no earnings)
Talking about revenue. SSH has mentioned that the reimbursement has been approved since March this year. Why still don't show the revenue in the income statement even after the second quarter ? If then, when will the revenue be posted ?
If the $IBB shakes out below the 50dma range to around $175-180 then there's no reason $SSH shouldn't go to its 50dma. Too many IPOs lately, too much easy money. Biotech-ers need to experience some real, scream-out-loud pain before we continue higher. 90% cash here, but no way I'm shorting anything.
That is the million dollar question. I already have a good amount shares but wouldnt mind a pull back either so I can buy some for my IRA. We had a great string of good press that ran this up quickly. If we do not get any good news in the new 3-4 weeks than yes I see this maybe going ot the 7's but cant imagine anything lower than that.